scholarly journals The Huntington disease protein accelerates breast tumour development and metastasis through ErbB2/HER2 signalling

2013 ◽  
Vol 5 (2) ◽  
pp. 309-325 ◽  
Author(s):  
Cristovão Moreira Sousa ◽  
John Russel McGuire ◽  
Morgane Sonia Thion ◽  
David Gentien ◽  
Pierre de la Grange ◽  
...  
Neurology ◽  
1981 ◽  
Vol 31 (8) ◽  
pp. 1003-1003 ◽  
Author(s):  
R. N. Rosenberg ◽  
N. Ivy ◽  
J. Kirkpatrick ◽  
C. Bay ◽  
W. L. Nyhan ◽  
...  

2010 ◽  
Vol 285 (17) ◽  
pp. 13142-13153 ◽  
Author(s):  
Jeffrey N. Savas ◽  
Bin Ma ◽  
Katrin Deinhardt ◽  
Brady P. Culver ◽  
Sophie Restituito ◽  
...  

2002 ◽  
Vol 22 (5) ◽  
pp. 1277-1287 ◽  
Author(s):  
Shi-Hua Li ◽  
Anna L. Cheng ◽  
Hui Zhou ◽  
Suzanne Lam ◽  
Manjula Rao ◽  
...  

ABSTRACT Polyglutamine expansion causes Huntington disease (HD) and at least seven other neurodegenerative diseases. In HD, N-terminal fragments of huntingtin with an expanded glutamine tract are able to aggregate and accumulate in the nucleus. Although intranuclear huntingtin affects the expression of numerous genes, the mechanism of this nuclear effect is unknown. Here we report that huntingtin interacts with Sp1, a transcription factor that binds to GC-rich elements in certain promoters and activates transcription of the corresponding genes. In vitro binding and immunoprecipitation assays show that polyglutamine expansion enhances the interaction of N-terminal huntingtin with Sp1. In HD transgenic mice (R6/2) that express N-terminal-mutant huntingtin, Sp1 binds to the soluble form of mutant huntingtin but not to aggregated huntingtin. Mutant huntingtin inhibits the binding of nuclear Sp1 to the promoter of nerve growth factor receptor and suppresses its transcriptional activity in cultured cells. Overexpression of Sp1 reduces the cellular toxicity and neuritic extension defects caused by intranuclear mutant huntingtin. These findings suggest that the soluble form of mutant huntingtin in the nucleus may cause cellular dysfunction by binding to Sp1 and thus reducing the expression of Sp1-regulated genes.


2019 ◽  
Vol 218 (6) ◽  
pp. 1972-1993 ◽  
Author(s):  
Manish Sharma ◽  
Srinivasa Subramaniam

Tunneling nanotubes (TNT) are thin, membranous, tunnel-like cell-to-cell connections, but the mechanisms underlying their biogenesis or functional role remains obscure. Here, we report, Rhes, a brain-enriched GTPase/SUMO E3-like protein, induces the biogenesis of TNT-like cellular protrusions, “Rhes tunnels,” through which Rhes moves from cell to cell and transports Huntington disease (HD) protein, the poly-Q expanded mutant Huntingtin (mHTT). The formation of TNT-like Rhes tunnels requires the Rhes’s serine 33, C-terminal CAAX, and a SUMO E3-like domain. Electron microscopy analysis revealed that TNT-like Rhes tunnels appear continuous, cell–cell connections, and <200 nm in diameter. Live-cell imaging shows that Rhes tunnels establish contact with the neighboring cell and deliver Rhes-positive cargoes, which travel across the plasma membrane of the neighboring cell before entering it. The Rhes tunnels carry Rab5a/Lyso 20-positive vesicles and transport mHTT, but not normal HTT, mTOR, or wtTau proteins. SUMOylation-defective mHTT, Rhes C263S (cannot SUMOylate mHTT), or CRISPR/Cas9-mediated depletion of three isoforms of SUMO diminishes Rhes-mediated mHTT transport. Thus, Rhes promotes the biogenesis of TNT-like cellular protrusions and facilitates the cell–cell transport of mHTT involving SUMO-mediated mechanisms.


2021 ◽  
Author(s):  
Angélica Martínez-López ◽  
Ana García-Casas ◽  
Paloma Bragado ◽  
Akira Orimo ◽  
Eduardo Castañeda-Saucedo ◽  
...  

1995 ◽  
Vol 1 (7) ◽  
pp. 644-648 ◽  
Author(s):  
Makoto Katsumata ◽  
Tadao Okudaira ◽  
Arabinda Samanta ◽  
Douglas P. Clark ◽  
Jeffrey A. Drebin ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document